Ernest S. Han, M.D., Ph.D.
Ernest Han, M.D., Ph.D., is associate professor and chief of the Division of Gynecologic Oncology, Department of Surgery, at City of Hope. He is an active physician-scientist who is dedicated to achieving the highest level of surgical cancer care through both open and minimally invasive techniques. His research focuses on developing advanced surgical technologies for the treatment of ovarian and other cancers.
One of his primary specialties is the use of imaging tools in the operating room to improve diagnostic evaluation of cancer during surgery. This may help to achieve the complete surgical removal of cancer. His research also focuses on advancing surgical outcomes and improving patient experiences related to cancer surgery.
Dr. Han serves as the program director for the Accreditation Council for Graduate Medical Education-accredited gynecologic oncology fellowship. He is committed to educating and training our future gynecologic oncologists to provide comprehensive and compassionate care for women affected by gynecologic cancers.
Duarte - Main Campus
Duarte, CA 91010
2004-2024, Diplomate of the American Board of Obstetrics and Gynecology
1994-2000, University of Texas Medical Branch, Galveston, M.D.
1992-2000, University of Texas Medical Branch, Galveston, Ph.D., Cell Physiology and Molecular Biophysics
1988-1992, University of California Berkeley, Berkeley, CA, B.A., Molecular and Cellular Biology
2004-present, University of California Irvine, Orange, CA, Fellowship, Gynecologic Oncology
2000-2004, Brown University, Women and Infants Hospital, Providence, RI, Residency, Obstetrics and Gynecology
2020-Present Program Director, ACGME Gynecologic Oncology Fellowship Program, City of Hope, Duarte, CA
2021-present, Associate Professor, Department of Surgery, Division of Gynecologic Oncology, City of Hope, Duarte, CA
2021-present, Chief, Division of Gynecologic Oncology, Department of Surgery, City of Hope, Duarte, CA
Awards
- 2016-2017 Super Faculty, Surgical Oncology, City of Hope
- 2010-2023 Top Doctor, Castle Connolly
- 2013-2023 Top Doctor, Pasadena Magazine
- 2011-2022 Top Doctor, Palm Springs Life
- 2021 PX Excellence, 4.9- or 5-Star Rafing on Press Ganey CG-CAHPS Survey, City of Hope
- 2020, Hope Colleague Award, City of Hope
- 2022, Hope Colleague Award, City of Hope
- 2022 Pafient Experience Award - Honorable Menfion of Hope
- 2021-2022 GME Excellence in Teaching Award, City of Hope
Memberships
- 2005-present, American Society of Clinical Oncologists (ASCO), Full Member
- 2005-present, Society of Gynecologic Oncologists (SGO), Full Member
- 2007-present, American College of Obstetricians and Gynecologists (ACOG), Full Member
- 2012-present, Internafional Gynecologic Cancer Society (IGCS), Full Member
- Shim SH, Chae SH, So KA, Lee SJ, Lee JY, Kim TJ, Han ES, Kang SB. Optimal duration of fertility-sparing hormonal treatment for early-stage endometrioid endometrial cancer. Gynecol Oncol. 2021 Jun;161(3):810-816. doi: 10.1016/j.ygyno.2021.03.032. Epub 2021 Apr 17. PMID: 33875233.
- Thornblade LW, Han ES, Fong Y., Colorectal Cancer Ovarian Metastases. Int J Gynecol Cancer. 2021 Aug;31(8):1137-1144. Epub 2021 Jun 3. PubMed PMID: 34083378
- Aritro Nath, Patrick Cosgrove, Hoda Mirsafian, Elizabeth Christie, Lance Pflieger, Benjamin Copeland, Sumana Majumdar, Mihaela Cristea, Han ES, Stephen Lee, Edward Wang, Sian Fereday, Nadia Traficante, Ravi Salgia, Theresa Werner, Adam Cohen, Philip Moos, Jeffrey Chang, David Bowtell, and Andrea Bild, Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer", Nat Commun. 2021 May 24;12(1):3039 2021 PMID: 34031395
- Woo Y, Chaurasiya S, O'Leary M, Han ES, Fong Y. Fluorescent imaging for cancer therapy and cancer gene therapy. Mol Ther Oncolytics. 2021 Jun 24;23:231-238. doi: 0.1016/j.omto.2021.06.007. eCollection 2021 Dec 17. PMID: 34729398
- Kohut, A., Whitaker, T., Walter, L., Li, S. Y., Han, E., Lee, S., Wakabayashi, M. T., Dellinger, T. H., Han, E. S., Rodriguez-Rodriguez, L. R., & Chung, C. (2022). Feasibility of combining pelvic reconstruction with gynecologic oncology-related surgery. International Urogynecology Journal. 2022 May DOI: 10.1007/s00192-022-05212-7. PMID: 35501570
- Dellinger TH, Han ES, Raoof M, Lee B, Wu X, Cho H, He T, Lee P, Razavi M, Liang W, Schmolze D, Priceman S, Lee S, Lin W, Lin J, Kebria M, Hakim A, Ruel N, Stewart D, Wang E, Paz B, Wakabayashi MT, Cristea MC, Rodriguez-Rodriguez L. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) induced molecular changes in humans validate preclinical data in ovarian cancer. JCO Precision Oncology, JCO Precis Oncol. 2022 Mar;6:e2100239. doi: 10.1200/PO.21.00239. PMID: 35357903
- Christina H. Wei, Susan Shehayeb, Nicole Lugo Santiago, Laura Kruper, Han ES, Edward Wang, Mihaela Cristea, Lorna Rodriguez-Rodriguez, Daphne Stewart, BRCA germline mutations in multiethnic gynecologic patients: A 10-year retrospective analysis from a single cancer institute, PLoS One. 2023 Jun 13;18(6):e0286998. doi: 10.1371/journal.pone.0286998. eCollection 2023. PMID: 37310942
- A.M. Reb, D. Economou, D.G. Cope, T. Borneman, M.S. Tejada, E.S. Han, M. Cristea, B.R. Ferrell, Care Processes and Quality-of-Life Outcomes Affecting the Gynecologic Cancer Survivorship Experience, Oncology Nursing Forum. 50 (2023) 185–200.
- Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han ES, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal S., Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw,. 2023 Feb;21(2):181-209. doi: 10.6004/jnccn.2023.0006. PMID: 36791750
- Adamson AW, Ding YC, Steele L, Leong LA, Morgan R, Wakabayashi MT, Han ES, Dellinger TH, Lin PS, Hakim AA, Wilczynski S, Warden CD, Tao S, Bedell V, Cristea MC, Neuhausen SL. Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Res Sq [Preprint]. 2023 Feb 20:rs.3.rs-2592107. doi: 10.21203/rs.3.rs-2592107/v1. PMID: 36865331; PMCID: PMC9980206
Visit PubMed to view Ernest Han's full list of publications.